A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase III Study to Investigate Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND)
Henry Ma(Monash University), Rohan Grimley(MACOM (United States)), Chung Y. Hsu(Kaohsiung Medical University), Graeme J. Hankey, Leonid Churilov(The University of Melbourne), Martín Krause(University Hospital Schleswig-Holstein), Simon McBride(Commonwealth Scientific and Industrial Research Organisation), Bernard Yan(Centre hospitalier universitaire d'Orléans), Tissa Wijeratne(Sunshine Hospital), Timothy Kleinig(Royal Adelaide Hospital), David Blacker(Sir Charles Gairdner Hospital), Geoffrey A. Donnan(The Royal Melbourne Hospital), Thanh G. Phan(Monash Health), Patricia Desmond, Stephen M. Davis(The Royal Melbourne Hospital), Chris Bladin(Box Hill Hospital), David W. Howells(The University of Melbourne), Neil Mahant(MACOM (United States)), Bruce Campbell(The Royal Melbourne Hospital), Sören Christensen(The Royal Melbourne Hospital), Richard Gerraty(Epworth Hospital), Mark Parsons(UNSW Sydney), Leanne Carey(The University of Melbourne), Alan Connelly(Mercer University), A. Lee(Flinders Medical Centre), Romesh Markus(MACOM (United States)), Stephen Read(UNSW Sydney), J Sturm(Gosford Hospital)
Cited by 198
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k